Преглед тема: "Parkinson's disease"
Приказ резултата 1-7 од 7
-
Association of catechol-O-methyltransferase gene polymorphisms with treatment response and levodopa-induced complications in Parkinson's disease: A summary of current knowledge / Udruženost polimorfizama gena za katehol-O- metiltransferazu sa terapijskim odgovorom i komplikacijama izazvanim levodopom kod Parkinsonove bolesti: Rezime sadašnjih saznanja
(Beograd : Savez farmaceutskih udruženja Srbije, Beograd : Univerzitet u Beogradu - Farmaceutski fakultet, 2024) -
Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy
(Elsevier Science BV, Amsterdam, 2006) -
Korelacija odabranih genetičkih polimorfizama i komplikacija dugotrajne primene levodope kod osoba koje boluju od Parkinsonove bolesti / The correlation of selected genetic polymorphisms and complications of long-term use of levodopa in individuals with Parkinson's disease
(Универзитет у Београду, Фармацеутски факултет, 2022) -
Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease
(Taylor & Francis Ltd, Abingdon, 2018) -
Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease
(Taylor & Francis Ltd, Abingdon, 2018) -
Vitamin D Serum Levels and Vitamin D Receptor Genotype in Patients with Parkinson's Disease
(Elsevier Ltd, 2023)